Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

Announcement on Shareholding Reduction Plan of Senior Executive

· Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Dizal (Jiangsu) Pharmaceutical Co. Ltd. has announced a shareholding reduction plan for several senior executives due to personal funding needs. The executives involved include the Chief Financial Officer and several Vice Presidents, each planning to reduce their holdings through a centralized bidding process. The company assures that this reduction will not affect its governance or ongoing operations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Later from Dizal (Jiangsu) Pharmaceutical

All Dizal (Jiangsu) Pharmaceutical news releases